Article Versions Notes

van der Veen SJ, Vlietstra WJ, van Dussen L, van Kuilenburg ABP, Dijkgraaf MGW, Lenders M, Brand E, Wanner C, Hughes D, Elliott PM, et al. Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease. International Journal of Molecular Sciences. 2020; 21(16):5784. https://doi.org/10.3390/ijms21165784

van der Veen, Sanne J., Wytze J. Vlietstra, Laura van Dussen, André B.P. van Kuilenburg, Marcel G. W. Dijkgraaf, Malte Lenders, Eva Brand, Christoph Wanner, Derralynn Hughes, Perry M. Elliott, and et al. 2020. "Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease" International Journal of Molecular Sciences 21, no. 16: 5784. https://doi.org/10.3390/ijms21165784

van der Veen, S. J., Vlietstra, W. J., van Dussen, L., van Kuilenburg, A. B. P., Dijkgraaf, M. G. W., Lenders, M., Brand, E., Wanner, C., Hughes, D., Elliott, P. M., Hollak, C. E. M., & Langeveld, M. (2020). Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease. International Journal of Molecular Sciences, 21(16), 5784. https://doi.org/10.3390/ijms21165784